1. Clinical utility of the 21-gene Oncotype DX® Recurrence Score® (RS) assay in hormone receptor-positive, HER2-negative breast cancer (BC). (March 2017) Authors: Lau, A.; Miller, D.; Davison, D.; Rothney, M.; Borgen, P. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term Anticoagulant Therapy after Myocardial Infarction in Women. Issue 5618 (7th September 1968) Authors: Borchgrevink, Chr. F.; Bjerkelund, Chr.; Abrahamsen, A. M.; Bay, G.; Borgen, P.; Grande, B.; Helle, I.; Kjörstad, H.; Petersen, A. M.; Rörvik, T.; Thorsen, R.; Ödegaard, A. Journal: BMJ Issue: Volume 3:Issue 5618(1968) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Male DCIS diagnosed after use of over-the-counter hormonal supplement. (2019) Authors: Agbroko, S.O.; Rojas, K.E.; Manasseh, D.M.; Borgen, P. Journal: International journal of surgery case reports Issue: Volume 57(2019) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗